Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 3.0Nanoscale Advances

Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells

  1. 1Laser Research Centre, University of Johannesburg, Doornfontein Campus Johannesburg South Africa

Abstract

With cancer's rising incidence and mortality rates expected to increase sharply by 2030, cancer continues to be a major worldwide health concern. Drug resistance, non-specific toxicity, and the persistence of cancer stem cells (CSCs), which cause tumor recurrence, metastasis, and therapeutic resistance, frequently limit conventional therapies. Although photodynamic therapy (PDT) provides a less intrusive option, tumor hypoxia, low photosensitizer (PS) selectivity, and restricted light penetration limit its therapeutic usefulness. Because of their remarkable optical characteristics, biocompatibility, adjustable surface chemistry, and inherent photosensitizing powers, carbon quantum dots (CQDs) have become a viable nanoplatform for cancer treatment. This review offers a comprehensive synthesis of current developments in CQD-based PDT for CSC and cancer cell targeting. The principles of PDT, CQD synthesis, and physicochemical characteristics; surface functionalization techniques using targeting ligands and stimuli-responsive moieties; and active targeting methods such as passive (enhanced permeability and retention (EPR) effect), active (ligand–receptor interactions), and organelle-specific targeting are all methodically examined. CQD-based methods for targeting CSC-like populations such as surface-functionalized CQDs for CSC indicators, ROS-mediated apoptosis, ferroptosis induction, and immunogenic cell death, are given particular attention. Highlighted are recent developments in upconversion systems, metal-doped hybrids, near-infrared (NIR)-activated CQDs, and combination treatments. However, direct experimental evidence that supports the efficacy of CQD-mediated PDT against CSCs remains limited, and most studies infer CSC-targeting potential from experiments conducted in cancer cell line. Challenges limiting the application of CQDs such as low quantum yield, tumor hypoxia, long-term biosafety, synthesis standardization, and clinical translation barriers were discussed, alongside emerging trends in personalized nanomedicine, AI-assisted design, and integration with gene therapy.

Related

  1. Measurement-efficient energy estimator for quantum chemistry of photodynamic materials
    Connor Lenihan, Kripa Panchagnula, Luca Erhart +14
    arXivPreprintarXiv licenceFull textPhysical chemistryQuantum physics & quantum informationarXiv
  2. From Mitochondrial Targeting to Microbial Killing: Twinkle-Derived Peptides as an Emerging Class of Potent AMPs
    Alessandra Porritiello, Emanuela Galatola, Bruna Agrillo +14
    ACS OmegaPeer-reviewedCC BY 4.0Full textGeneral chemistryCrossref
  3. Chlorate as an emerging contaminant in water and food matrices: Sources, occurrence, toxicity, analytical methods, and mitigation strategies: A critical review
    Youssef Ali, Pascal Mailley, Valerie Gaudin
    Food and HumanityPeer-reviewedCC BYAnalytical chemistryHAL
  4. Nanocarrier-Mediated Immunotherapy for Gynecological Malignancies: Mechanisms, Clinical Translation, and Emerging Nucleic Acid-Based Strategies.
    Miaomiao Fu, Ruimin Zhao, Yiyan Cao +3
    International journal of nanomedicinePeer-reviewedCC BY-NCFull textMaterials & polymersEurope PMCPMC
  5. Advances in Aqueous Electrolyte Engineering: From Fundamental Limitations to Emerging Strategies
    Yong-Gang Sun, Yi-Han Zhang, Jian Xiong +6
    MoleculesPeer-reviewedCC BY 4.0Full textGeneral chemistryCrossrefEurope PMC
BibTeX
@article{kah2026carbon,
  title = {{Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells}},
  author = {Glory Kah and Heidi Abrahamse},
  journal = {Nanoscale Advances},
  year = {2026},
  month = nov,
  doi = {10.1039/d6na00732e},
  url = {https://doi.org/10.1039/d6na00732e},
  note = {CC BY-NC 3.0},
}
RIS
TY  - JOUR
TI  - Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells
AU  - Glory Kah
AU  - Heidi Abrahamse
PY  - 2026
DA  - 2026/11/12
JO  - Nanoscale Advances
DO  - 10.1039/d6na00732e
UR  - https://doi.org/10.1039/d6na00732e
AB  - With cancer's rising incidence and mortality rates expected to increase sharply by 2030, cancer continues to be a major worldwide health concern. Drug resistance, non-specific toxicity, and the persistence of cancer stem cells (CSCs), which cause tumor recurrence, metastasis, and therapeutic resistance, frequently limit conventional therapies. Although photodynamic therapy (PDT) provides a less intrusive option, tumor hypoxia, low photosensitizer (PS) selectivity, and restricted light penetration limit its therapeutic usefulness. Because of their remarkable optical characteristics, biocompatibility, adjustable surface chemistry, and inherent photosensitizing powers, carbon quantum dots (CQDs) have become a viable nanoplatform for cancer treatment. This review offers a comprehensive synthesis of current developments in CQD-based PDT for CSC and cancer cell targeting. The principles of PDT, CQD synthesis, and physicochemical characteristics; surface functionalization techniques using targeting ligands and stimuli-responsive moieties; and active targeting methods such as passive (enhanced permeability and retention (EPR) effect), active (ligand–receptor interactions), and organelle-specific targeting are all methodically examined. CQD-based methods for targeting CSC-like populations such as surface-functionalized CQDs for CSC indicators, ROS-mediated apoptosis, ferroptosis induction, and immunogenic cell death, are given particular attention. Highlighted are recent developments in upconversion systems, metal-doped hybrids, near-infrared (NIR)-activated CQDs, and combination treatments. However, direct experimental evidence that supports the efficacy of CQD-mediated PDT against CSCs remains limited, and most studies infer CSC-targeting potential from experiments conducted in cancer cell line. Challenges limiting the application of CQDs such as low quantum yield, tumor hypoxia, long-term biosafety, synthesis standardization, and clinical translation barriers were discussed, alongside emerging trends in personalized nanomedicine, AI-assisted design, and integration with gene therapy.
SN  - 2516-0230
ER  -